AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial

Study will evaluate AtaCor's investigational Atala™ lead in conjunction with Abbott's investigational EV-ICD pulse generator Study will evaluate a novel parasternal extravascular ICD approach for the treatment of life-threatening ventricular tachyarrhythmias SAN CLEMENTE, Calif., July 7,...